Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Insignia Financial Ltd ( (AU:IFL) ) has shared an announcement.
Insignia Financial Ltd has notified Immutep Limited that, as of 13 March 2026, it has ceased to be a substantial holder in the biotech company. The change follows a series of on‑market transactions by its IOOF and MLC-branded investment entities between September and December 2024, involving both purchases and sales of Immutep shares that ultimately reduced its overall stake below the substantial holding threshold.
The filing details an extended period of active portfolio rebalancing across multiple Insignia-controlled vehicles, reflecting shifting exposure to Immutep rather than a single large divestment. For Immutep shareholders, the move signals that a previously significant institutional investor has scaled back its position, which may influence trading liquidity and the company’s institutional ownership profile over time.
The most recent analyst rating on (AU:IFL) stock is a Hold with a A$4.80 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
More about Insignia Financial Ltd
Insignia Financial Ltd is an Australian financial services group that operates through subsidiaries including IOOF Investment Management and IOOF Investment Services. The group focuses on investment management and related financial products, actively trading listed securities on behalf of its clients and managed funds in the local equity market.
Average Trading Volume: 1,746,946
Technical Sentiment Signal: Buy
Current Market Cap: A$3.13B
For detailed information about IFL stock, go to TipRanks’ Stock Analysis page.